During the past decade, Won-Suk Lee conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Won-Suk Lee" are "Colorectal Cancer With Liver Metastasis" (1 trials), "Patient Under Going Colorectal and Stomach Cancer Surgery" (1 trials) and "Stage IV Colon Cancer" (1 trials). Many other conditions were trialed in "Won-Suk Lee" in a lesser frequency.

Most popular intervention types in "Won-Suk Lee" are "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Guardix" (1 trials), "Oophrectomy" (1 trials), "Seprafilm" (1 trials) and "perihepatic lymphadenectomy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Won-Suk Lee" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Won-Suk Lee". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Won-Suk Lee, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Won-Suk Lee, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".